D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
NXGN holding history
Nextgen Healthcare, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NXGN overviewAll 13F holders of NXGNFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −157,415−100.0% | Sold out | Holders |
| Q3 2023 | 157,415 | $3.74M | <0.1% | −99,887−38.8% | Reduced | Holders |
| Q2 2023 | 257,302 | $4.17M | <0.1% | +25,652+11.1% | Added | Holders |
| Q1 2023 | 231,650 | $4.03M | <0.1% | +112,387+94.2% | Added | Holders |
| Q4 2022 | 119,263 | $2.24M | <0.1% | +89,584+301.8% | Added | Holders |
| Q3 2022 | 29,679 | $525.0K | <0.1% | −37,561−55.9% | Reduced | Holders |
| Q2 2022 | 67,240 | $1.17M | <0.1% | −90,867−57.5% | Reduced | Holders |
| Q1 2022 | 158,107 | $3.31M | <0.1% | −105,508−40.0% | Reduced | Holders |
| Q4 2021 | 263,615 | $4.69M | <0.1% | +55,953+26.9% | Added | Holders |
| Q3 2021 | 207,662 | $2.93M | <0.1% | +24,465+13.4% | Added | Holders |
| Q2 2021 | 183,197 | $3.04M | <0.1% | +17,317+10.4% | Added | Holders |
| Q1 2021 | 165,880 | $3.00M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.